Use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and lipid-lowering therapies among Rhode Islanders with diabetes enrolled in Medicare Part D plans in 2006 and 2007.

Stephen Kogut, University of Rhode Island
Aisling Caffrey, University of Rhode Island
Lynn Pezzullo, University of Rhode Island

Abstract